Bridging Innovative RNA Biology and Drug Discovery
Our mission:
By combining multidisciplinary academic innovators with biotech-inspired objectives and focus, our goal is to uncover novel disease solutions by advancing the science of RNA regulation, developing new technological platforms, and discovering early-stage therapeutics.
Our Approach:
Recruit and nucleate current and next generation leaders in RNA biology and cultivate environment of collaboration, technology innovation and entrepreneurship
Build multi-disciplinary drug discovery teams focused on translating transformative RNA discoveries into therapeutics utilizing biotech best practices
Integrate academic innovators with therapeutic teams to bridge the gap between discovery and clinically applicable therapies
CENTER Happenings
recent media & publications
Drs. Nick Neill and Trey Westbrook recently published “Integrative proteogenomics and forward genetics reveals a novel mitotic vulnerability in triple-negative breast cancer” in Cancer Discovery. Congratulations!
Congratulations to Khoa Dao, Dr. Tony Mustoe, and colleagues for their recent publication “U-rich elements drive pervasive cryptic splicing in 3’ UTR massively parallel reporter assays” in Nature Communications!
Congrats to Joey Song, Dr. Eric Van Nostrand, and colleagues for their Genome Biology publication “Mapping snoRNA-target RNA interactions in an RNA-binding protein-dependent manner with chimeric eCLIP”!
upcoming events
Our next THINC Seminar Series will be September 24th, at 3pm at Helix Park-Dynamic One. We are pleased to welcome Charles Lin, Executive Director at Amgen, who will be our featured speaker. Additional details, including the seminar title will be shared soon. Hope to see you there!
Our next RNA Group will be September 22nd, at 10am in M112. Rong-Chi Hu from Cooper Lab (BCM) and Mario Cabrera from Hodges Lab (BCM) will present their work. Hope to see you there!